# DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM
> **ANDA203594** · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS INC · Approved 2016-10-11
## Drug
- **FDA Application Number:** ANDA203594
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM
- **Generic name:** Drospirenone
- **Active ingredients:** DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** WATSON LABS INC
- **First approval:** 2016-10-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203594)
---
*AI Analytics · CC0 1.0*